What Are the Latest Developments in Immunotoxin Research?
Recent advancements in genetic engineering and protein design have led to the development of next-generation immunotoxins with enhanced efficacy and reduced immunogenicity. Researchers are exploring novel delivery systems to improve the targeting and internalization of immunotoxins. Clinical trials are ongoing to evaluate the safety and efficacy of these new formulations in various cancer types.
